- Release Date: 13/03/23 09:10
- Summary: FDA approves Daybue - the first treatment for Rett syndrome
- Price Sensitive: Yes
- Download Document 258.83KB
Ann: FDA approves Daybue - the first treatment for Rett syndrome
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.65 |
Change
-0.620(2.91%) |
Mkt cap ! $2.657B | |||
| Open | High | Low | Value | Volume |
| $20.98 | $21.06 | $20.40 | $1.487M | 71.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57 | $20.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.66 | 52 | 4 |
View Market Depth
| Last trade - 11.42am 01/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |